Stock Events

Stock Events

Search...

Sangamo Therapeutics (SGMO) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.59

-0.46

-0.34

-0.21

Details

Expected EPS

-0.21375

Actual EPS

-0.27

Surprise EPS

-0.06

Surprise Percent

+26.32%

Description

Sangamo Therapeutics (SGMO) has reported earnings of -0.27 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.